Qube Research & Technologies LTD Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$144.95 - $152.29 $15.7 Million - $16.5 Million
108,582 Added 1690.52%
115,005 $17.4 Million
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $534,008 - $937,693
6,423 New
6,423 $936,000
Q3 2021

Nov 12, 2021
SELL
$98.85 - $138.91 $2.66 Million - $3.74 Million
-26,937 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$65.78 - $105.02 $1.77 Million - $2.83 Million
26,937 New
26,937 $2.62 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email